In humans, genetic deficiency of AID leads to Type-2 Hyper-IgM Syndrome (HIGM2), an immunodeficiency characterized by the absence of antibodies other than the IgM class (Revy et al., 2000). This evidence concerns the gene AICDA and hyper-IgM syndrome type 2.